COMIRNATY XFG (30 Mikrogramm) Injektionsdispersio

7680708930019 CH-70893 J07BN01 08.08.

No images available

Details

Product number
7089301
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
Suspension: COVID-19 mRNA XFG 30 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas) pro dosi, 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum pro dosi, 1,2-distearoyl-sn-glycero-3-phosphocholinum pro dosi, cholesterolum pro dosi, saccharum pro dosi, trometamolum pro dosi, trometamoli hydrochloridum pro dosi, aqua ad iniectabile, pro dosi pro dosi.

Articles (1)

Comirnaty XFG (30 Mikrogramm) Injektionsdispersion in einer Fertigspritze
Fertigspritze
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/08/2026
Patient information leaflet
Français
14/08/2026
Patient information leaflet
Italien
14/08/2026
Professional SmPC
Allemand
14/08/2026
Professional SmPC
Français
14/08/2026
Professional SmPC
Italien
14/08/2026

Detailed composition

Substance Quantity Type Category
COVID-19 mRNA XFG
30.0 UG Substance Wirkstoff (Principe actif)
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas)
- Substance HNIDK
2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum
- Substance HNIDK
1,2-distearoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
cholesterolum
- Substance HNIDK
saccharum
- Substance HNIDK
trometamolum
- Substance HNIDK
trometamoli hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 89.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
70893
Drug name
Comirnaty XFG, Injektionsdispersion in einer Fertigspritze
Galenic form
INFFS
ATC Code
J07BN01
Authorization status
Z
Dispensation category
B
First authorization
10/08/2026
Authorization expiration date
09/08/2031
IT number
08.08.
Domain
Human medicine
Field of application
Comirnaty XFG (30 Mikrogramm)/Dosis gebrauchsfertige Injektionsdispersion ist indiziert für die aktive Immunisierung zur Vorbeugung der durch das SARS-CoV-2-Virus hervorgerufenen COVID-19-Erkrankung bei Personen ab 12 Jahren.

Packaging details

Description (FR)
COMIRNATY XFG (30 Mikrogramm) Injektionsdispersio
Description (DE)
COMIRNATY XFG (30 Mikrogramm) Injektionsdispersio
Market launch
10/08/2026
Narcotic (BTM)
No

Other packaging sizes

COMIRNATY XFG (30 Mikrogramm) Injektionsdispersio
10 FESP
GTIN: 7680708930026
View
Buy us a coffee Explore the data